New 1064nm delivery system makes PicoSure the first true three-wavelength platform

Cynosure has announced a new FDA-approved delivery system for PicoSure, the world’s first aesthetic picosecond laser. Together with the FDA cleared 532nm and 755nm wavelengths, Cynosure’s new 106 nm Laser Delivery System improves the multi-wavelength laser technology for removing the full colour spectrum of tattoo inks in fewer treatments. This makes PicoSure the first true three-wavelength platform. 

Engineered to complement the highly versatile 755 nm wavelength and the FOCUS Lens Array, the 1064 nm and 532 nm Laser Delivery Systems enhance PicoSure’s ability to remove tattoos and treat a range of dermatologic conditions including wrinkles, acne scars and pigmented lesions.